Bharat Biotech Submits Covaxin Phase 3 Trial Data; Expert Panel Meet Today

Bharat Biotech on Tuesday submitted Phase III trial data for the Covaxin coronavirus vaccine to the DCGI (Drug Controller General of India), whose SEC (subject expert committee) is expected to meet...

from NDTV News - Topstories https://ift.tt/3vSHX1S
https://ift.tt/eA8V8J